Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin PD Model Validation for Pain Relief
NCT04435704Phase 2Withdrawn
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in osteoarthritis (OA), sponsored by Wake Forest University Health Sciences. Planned start Jan 2025; status: withdrawn.
02
Drugs
oxytocin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04435704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04435704.